Ask a Lymphoma/CLL Specialist

Our next Q&A Session will take place on June 25^th, 2026

from 4-5pm EST

Our guest is Dr. Mona Shafey

Get your Questions Answered by a leading Lymphoma/CLL Specialist!

Our Q&A program, “Ask a Lymphoma/CLL Specialist,” is a unique opportunity to get your questions answered by leading experts in the field of lymphoma and chronic lymphocytic leukemia (CLL). This session features Dr. Mona Shafey, a Clinical Associate Professor in the Department of Medicine, Division of Hematology, at the University of Calgary. Dr. Shafey will provide detailed, personalized responses to your most pressing questions, helping you navigate your journey with lymphoma or CLL with greater understanding and confidence.

We invite you to submit your questions in the forum below. Whether you’re curious about symptoms, treatment options, side effects, or daily management, no question is too big or too small. By participating, you not only get the chance to have your questions addressed but also contribute to a richer, more informed community discussion.

Don’t forget to register to attend the webinar live to hear Dr. Shafey’s answers to your questions. This is an excellent opportunity to gain insights directly from a top expert and learn from the experiences of others in the community. Join us for this insightful session and empower yourself with knowledge from one of the best in the field.

Submit your questions

Meet our specialist: Mona Shafey

Dr. Mona Shafey is a Clinical Associate Professor in the Division of Hematology and Hematological Malignancies. She completed medical school and residency training at the University of Ottawa in 2008 and completed fellowship training in Hematopoietic Stem Cell Transplantation at the University of Calgary in 2010.

She is currently the Medical Director of the Alberta Blood & Marrow Transplant Program, the Alberta Provincial Lead for Cellular Therapy, and the Associate Director of Clinical Research & Translation at the Riddell Centre for Cancer Immunotherapy.

Her clinical and research interests are in malignant hematology with a focus on the management of patients with lymphoma and CLL, including the use of cellular therapies in the treatment of these diseases.